Abstract 1630: Dysregulation of Hippo pathway in metastatic prostate cancer
Jen-Ming Huang(Cedars-Sinai Medical Center), Leland W.K. Chung(VA Palo Alto Health Care System), Hyung L. Kim(Cedars-Sinai Medical Center), Gina C-Y. Chu(Cedars-Sinai Medical Center), Haiyen E. Zhau(Cedars-Sinai Medical Center)
Cited by 0
Related Papers
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
|PubMed|1994|739
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
|Nature Protocols|2007|520
Insulin-like Growth Factor-I–Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
|Cancer Research|2008|384
MOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENT
|The Journal of Urology|2005|363